Project Details
Description
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/18 → 6/30/20 |
Funding
- CATABASIS PHARMACEUTICALS
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.